form6-k.htm
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

June 19, 2009

Commission File Number 001-14956

BIOVAIL CORPORATION
(Translation of Registrant’s name into English)

7150 Mississauga Road, Mississauga, Ontario, CANADA, L5N 8M5
(Address of principal executive office and zip code)

Registrant’s telephone number, including area code: (905) 286-3000

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 

Form 20-F x
  
Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).
 

Yes o
  
No x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).
 

Yes o
  
No x

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g 3-2(b) under the Securities Exchange Act of 1934.
 

Yes o
  
No x


 
 
 


 
 
 

 
 
 
 

BIOVAIL CORPORATION
 
This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the registration statements on Form S-8 (Registration Nos. 333-92229 and 333-138697) of Biovail Corporation.
 
INDEX
 
 
Exhibit 99.1  Material Change Report dated June 19, 2009 
   
Exhibit 99.2
 
 Credit Agreement, dated as of June 9, 2009 among Biovail Corporation, the lenders party hereto and JPMorgan Chase Bank, N.A., Toronto Branch, as Administrative Agent 
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Biovail Corporation
     
     
Date: June 19, 2009
By: 
/s/ Jennifer Tindale
   
Jennifer Tindale
   
Vice President &
   
Associate General Counsel